Steatohepatitis Center

  • Steatohepatitis Services

    Non-Alcoholic Fatty Liver Disease (NAFLD) is a growing epidemic

    With the growing obesity epidemic, NAFLD is now believed to be the most common liver disease worldwide, affecting up to 13 percent of children and one-third of adults. NASH affects 2-3 percent of all adults and children, but is found in approximately 25 percent of children who have fatty liver. Up to one-quarter of patients with NASH may go on to more severe fibrosis, cirrhosis and end-stage liver disease. The majority of patients with pediatric NAFLD  or NASH are overweight or obese, and many have associated health problems, such as insulin resistance, diabetes mellitus, obstructive sleep apnea, hypertension and dyslipidemia (features of metabolic syndrome).

    The Steatohepatitis Center can help

    Comprehensive clinical care includes:

    • Standardized care so each patient receives the highest quality and safest care
    • Standard screening for closely related obesity co-morbidities and needed referrals to other subspecialties (endocrinology, pulmonary medicine, cardiology) as needed
    • Comprehensive dietary assessments: a registered dietitian will complete and monitor a dietary assessment for all patients and offer family-based, individualized recommendations
    • Referral of interested patients to the Comprehensive Weight Management Program at Cincinnati Children’s, which includes both non-surgical (HealthWorks!) and surgical (Surgical Weight Loss Program for Teens) weight-management programs

    Cutting-edge research and trials: